Achillion Pharmaceuticals Inc (ACHN.O)
ACHN.O on Nasdaq
7.03USD
1 Aug 2013
7.03USD
1 Aug 2013
Price Change (% chg)
$-0.11 (-1.54%)
$-0.11 (-1.54%)
Prev Close
$7.14
$7.14
Open
$7.20
$7.20
Day's High
$7.21
$7.21
Day's Low
$7.00
$7.00
Volume
675,151
675,151
Avg. Vol
1,288,063
1,288,063
52-wk High
$11.36
$11.36
52-wk Low
$5.42
$5.42
About
Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the... (more)
Overall
| Beta: | 0.59 |
| Market Cap (Mil.): | $689.41 |
| Shares Outstanding (Mil.): | 96.56 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ACHN.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.64 | -- | -- |
| ROI: | -38.28 | -2.58 | 18.76 |
| ROE: | -38.40 | -2.66 | 19.59 |
UPDATE 1-FDA places clinical hold on Achillion's hep C drug, shares plunge
* Co says liver enzymes elevated in drug interaction with HIV drug
FDA places clinical hold on Achillion's hepatitis C drug
July 1 - Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on its hepatitis C drug sovaprevir after elevations in liver enzymes were noted in an early-stage study of the drug's interaction with an HIV drug.
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.11 | -0.12 |
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Merck & Co., Inc. (MRK.N) | $48.58 | +0.41 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| AstraZeneca plc (AZN.L) | 3,334.00p | -1.00 |
| GlaxoSmithKline plc (GSK.L) | 1,712.50p | +28.50 |
| Bristol Myers Squibb Co. (BMY.N) | $43.99 | +0.75 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

